National Quality Measures Clearinghouse | American Society of Hematology

National Quality Measures Clearinghouse | American Society of Hematology

1-4 of 4
1.   Hematology: percentage of patients aged 18 years and older with a diagnosis of chronic lymphocytic leukemia (CLL) who had baseline flow cytometry studies performed. 2010 Sep. NQMC:003161 American Society of Hematology - Medical Specialty Society; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. Collection: The Physician Consortium for Performance Improvement® Measurement Sets Compare Selected
2.   Hematology: percentage of patients aged 18 years and older with a diagnosis of multiple myeloma, not in remission, who were prescribed or received intravenous bisphosphonate therapy within the 12 month reporting period. 2010 Sep. NQMC:003160 American Society of Hematology - Medical Specialty Society; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. Collection: The Physician Consortium for Performance Improvement® Measurement Sets Compare Selected
3.   Hematology: percentage of patients aged 18 years and older with a diagnosis of myelodysplastic syndrome (MDS) or an acute leukemia who had baseline cytogenetic testing performed on bone marrow. 2010 Sep. NQMC:003158 American Society of Hematology - Medical Specialty Society; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. Collection: The Physician Consortium for Performance Improvement® Measurement Sets Compare Selected
4.   Hematology: percentage of patients aged 18 years and older with a diagnosis of myelodysplastic syndrome (MDS) who are receiving erythropoietin therapy with documentation of iron stores prior to initiating erythropoietin therapy. 2010 Sep. NQMC:003159 American Society of Hematology - Medical Specialty Society; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. Collection: The Physician Consortium for Performance Improvement® Measurement Sets